- Joe Tippens, diagnosed with terminal stage 4 small cell lung cancer, achieved remission using fenbendazole, a veterinary dewormer, combined with natural compounds.
- Over 110,000 members in online support groups report using fenbendazole and ivermectin to treat stage 4 cancer, but these treatments are largely ignored by mainstream medicine.
- Fenbendazole and ivermectin have shown efficacy against various cancers in preclinical studies, with regulatory hurdles preventing their FDA approval for cancer treatment.
- The suppression of these inexpensive, off-patent drugs is linked to pharmaceutical industry interests and regulatory actions against doctors advocating for their use.
- Patients are taking control of their health through online communities, and researchers like Dr. William Makis envision a future where these drugs are FDA-approved and accessible over the counter.
In 2017, Joe Tippens, a man diagnosed with terminal stage 4 small cell lung cancer, was sent home to die. His doctors had exhausted all conventional treatments, leaving him with less than a one percent chance of survival. But Tippens refused to give up. A friend suggested he try fenbendazole, a veterinary dewormer used to treat parasites in dogs. Desperate and with nothing to lose, Tippens combined fenbendazole with natural compounds like curcumin, CBD oil and vitamin E. Within months, his cancer was gone.
This miraculous recovery, once dismissed as an anomaly, has since sparked a grassroots medical revolution. Today, over 110,000 members in online support groups share stories of stage 4 cancer remissions using fenbendazole and its cousin, ivermectin – both repurposed anti-parasitic drugs. Yet, despite mounting evidence of their efficacy, these low-cost treatments remain largely ignored by mainstream medicine. Why?
Science behind the miracle
Fenbendazole and ivermectin are not new drugs. Fenbendazole, originally developed to treat parasites in animals, was accidentally discovered to have potent anticancer properties. Ivermectin, derived from soil microbes, has been used for decades to combat parasitic infections in humans and animals. Both drugs work by disrupting cellular processes critical to cancer survival.
Dr. William Makis, a radiologist, oncologist and cancer researcher, has been at the forefront of documenting these drugs' potential.
"Fenbendazole and ivermectin are being repurposed for cancer, and the results are astonishing," Makis explained during an interview with Mike Adams on a recent "Health Ranger Report" episode. "In preclinical studies, ivermectin has shown efficacy against 28 different cancers, with ovarian and breast cancers responding particularly well."
Stanford University researchers were so impressed by fenbendazole's success that they published a case series documenting three stage 4 cancer patients who achieved remission after failing all conventional treatments. Yet, due to regulatory hurdles, these drugs remain off-label for cancer treatment. (Related: Study outlines cases of people successfully treating cancer with fenbendazole protocol.)
Politics of suppression
The suppression of fenbendazole and ivermectin is not a conspiracy – it's a business model. Both drugs are off patent, meaning they are inexpensive and widely available. This poses a threat to the pharmaceutical industry, which profits from high-cost treatments like chemotherapy and experimental mRNA cancer vaccines.
Merck, the original patent holder for ivermectin, has a 50-50 partnership with Moderna to develop a $500,000 mRNA cancer vaccine currently in phase 3 trials.
"Ivermectin had to be suppressed for mRNA technology to get a green light," Makis, a renowned Canadian physician specializing in nuclear medicine, radiology and oncology, revealed while adding that it paved the way for emergency authorization approval and the rollout of the Wuhan coronavirus (COVID-19) vaccine.
The suppression extends beyond corporate interests. Doctors advocating for these treatments face unprecedented persecution. Dr. Pierre Kory and Dr. Paul Marik, prominent ivermectin advocates, were stripped of their board certifications for promoting its use during the COVID-19 pandemic. In Canada, a doctor who prescribed ivermectin was fined $40,000 and temporarily lost his license.
Despite the pushback, patients are taking their health into their own hands. Online communities like the Fenbendazole Cancer Support Group on Facebook provide a platform for sharing protocols, success stories, and resources. Many patients source fenbendazole and ivermectin from veterinary suppliers or international pharmacies, bypassing the need for expensive prescriptions.
Natural compounds like curcumin, CBD oil and vitamin E are often used alongside these drugs to enhance their effects.
Makis mentioned that CBD oil has cured lung cancer in some cases and patients who applied it topically for their skin cancer were also cured.
Future of cancer treatment
The potential of fenbendazole and ivermectin to revolutionize cancer treatment is undeniable. Yet, their widespread adoption depends on overcoming systemic barriers. Makis envisions a future where these drugs are Food and Drug Administration-approved and available over the counter, empowering patients to take control of their health.
"We need a complete reset in science and medicine," Makis asserted while also stressing a return to ethical practices, freedom of speech for doctors, and access to affordable, effective treatments. For now, the movement continues to grow, driven by the courage of patients and the dedication of researchers like Makis.
Follow Cancer.news for more news about ivermectin, fenbendazole and other drugs that fight cancer.
Watch the video below to know more about the interview of Dr. William Makis with Mike Adams.
This video is from the Health Ranger Report channel on Brighteon.com.
More related stories:
Sources include:
Please contact us for more information.